CRRC Corporation Limited - 1766.HK

1766.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
1766.HK	0	2.3	7.8	-5.4	-0.4	54.7	38.3	-14.9	-52.3	88.2
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare 1766.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	1766.HK
name	CRRC Corporation Limited
price	4.95
changes percentage	0
change	0
day low	4.92
day high	5.04
year high	6.12
year low	3.15
market cap	211671391165
price avg 50	4.7836
price avg 200	4.8111
exchange	HKSE
volume	19978730
avg volume	15503832
open	4.95
previous close	4.95
eps	0.48
pe	10.31
earnings announcement	2025-03-26T10:59:00.000+0000
shares outstanding	42761897205
timestamp	2025-01-20 08:08:32

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 60.7%

Overall Quarterly Financial Health: 57.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	234261514000	222938637000	5.08
gross profit	52160110000	47312860000	10.25
gross profit ratio	0.22	0.21	4.92
research and development expenses	14363696000	13129748000	9.40
operating expenses	36134350000	34097433000	5.97
interest income	1167824000	986017000	18.44
interest expense	72552000	1147726000	-93.68
ebitda	24123264000	23987753000	0.56
ebitdaratio	0.1	0.11	-2.35
operating income	16025760000	15979702000	0.29
operating income ratio	0.07	0.07	-4.56
net income	11711576000	11653448000	0.50
net income ratio	0.05	0.05	-4.36
eps	0.41	0.41	0.00

Overall Score of Annual Income Statement

0.86 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 234,262 million in 2023 from 222,939 million in 2022 representing a change of 5.08%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 52,160 million in 2023 from 47,313 million in 2022 representing a change of 10.25%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 14,364 million in 2023 from 13,130 million in 2022 representing a change of 9.4%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 24,123 million in 2023 from 23,988 million in 2022 representing a change of 0.56%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 16,026 million in 2023 from 15,980 million in 2022 representing a change of 0.29%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 11,712 million in 2023 from 11,653 million in 2022 representing a change of 0.5%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 36,134 million in 2023 from 34,097 million in 2022 representing a change of 5.97%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	62543500000	57856558000	8.10
gross profit	13093115000	11255508000	16.33
gross profit ratio	0.21	0.19	7.61
research and development expenses	3906471000	3354763000	16.45
operating expenses	8796450000	6663513000	32.01
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	3667173000	5481583000	-33.10
ebitdaratio	0.06	0.1	-40.55
operating income	4296665000	4563512000	-5.85
operating income ratio	0.07	0.08	-12.90
net income	3044125000	3192540000	-4.65
net income ratio	0.05	0.06	-11.79
eps	0.11	0.12	-8.33

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 62,544 million in 2024Q3 from 57,857 million in 2024Q2 representing a change of 8.1%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 13,093 million in 2024Q3 from 11,256 million in 2024Q2 representing a change of 16.33%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 3,906 million in 2024Q3 from 3,355 million in 2024Q2 representing a change of 16.45%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 8,796 million in 2024Q3 from 6,664 million in 2024Q2 representing a change of 32.01%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 3,667 million in 2024Q3 from 5,482 million in 2024Q2 representing a change of -33.1%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 4,297 million in 2024Q3 from 4,564 million in 2024Q2 representing a change of -5.85%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 3,044 million in 2024Q3 from 3,193 million in 2024Q2 representing a change of -4.65%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.11 in 2024Q3 from 0.11 in 2024Q2 representing a change of -8.33%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	471791735000	442140146000	6.71
total liabilities	275268420000	251154230000	9.60
total equity	196523315000	190985916000	2.90
cash and cash equivalents	55929833000	54861839000	1.95
short term investments	8932728000	10431092000	-14.36
long term investments	25989026000	10974153000	136.82
total current assets	314587463000	290455050000	8.31
total non current assets	157204272000	151685096000	3.64
total current liabilities	250407506000	227403751000	10.12
total non current liabilities	24860914000	23750479000	4.68
common stock	28698864000	28698864000	0.00
retained earnings	91556425000	79441376000	15.25
total debt	16659902000	27347788000	-39.08

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 471,792 million in 2023 from 442,140 million in 2022 representing a change of 6.71%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 196,523 million in 2023 from 190,986 million in 2022 representing a change of 2.9%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 55,930 million in 2023 from 54,862 million in 2022 representing a change of 1.95%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 314,587 million in 2023 from 290,455 million in 2022 representing a change of 8.31%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 91,556 million in 2023 from 79,441 million in 2022 representing a change of 15.25%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 16,660 million in 2023 from 27,348 million in 2022 representing a change of -39.08%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 275,268 million in 2023 from 251,154 million in 2022 representing a change of 9.6%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 8,933 million in 2023 from 10,431 million in 2022 representing a change of -14.36%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 250,408 million in 2023 from 227,404 million in 2022 representing a change of 10.12%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	501501315000	479499893000	4.59
total liabilities	297689529000	279593282000	6.47
total equity	203811786000	199906611000	1.95
cash and cash equivalents	48760864000	47742240000	2.13
short term investments	6631940000	7768559000	-14.63
long term investments	18962641000	17556177000	8.01
total current assets	339121469000	319587946000	6.11
total non current assets	162379846000	159911947000	1.54
total current liabilities	273467835000	255569971000	7.00
total non current liabilities	24221694000	24023311000	0.83
common stock	28698864000	28698864000	0.00
retained earnings	86068190000	83024066000	3.67
total debt	16308955000	21586345000	-24.45

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 501,501 million in 2024Q3 from 479,500 million in 2024Q2 representing a change of 4.59%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 203,812 million in 2024Q3 from 199,907 million in 2024Q2 representing a change of 1.95%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 48,761 million in 2024Q3 from 47,742 million in 2024Q2 representing a change of 2.13%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 339,121 million in 2024Q3 from 319,588 million in 2024Q2 representing a change of 6.11%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 86,068 million in 2024Q3 from 83,024 million in 2024Q2 representing a change of 3.67%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 16,309 million in 2024Q3 from 21,586 million in 2024Q2 representing a change of -24.45%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 297,690 million in 2024Q3 from 279,593 million in 2024Q2 representing a change of 6.47%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 6,632 million in 2024Q3 from 7,769 million in 2024Q2 representing a change of -14.63%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 273,468 million in 2024Q3 from 255,570 million in 2024Q2 representing a change of 7.0%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-1540541000	4329572000	-135.58
operating cash flow	14721616000	23953216000	-38.54
free cash flow	6617843000	16535757000	-59.98
capital expenditure	-8103773000	-7417459000	-9.25
depreciation and amortization	7677711000	7823849000	-1.87
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	38827807000	12498170000	210.67
inventory	-3876379000	-1878579000	-106.35
acquisitions net	0	0	NaN
investments in property plant and equipment	-8103773000	-7417459000	-9.25
net cash used for investing activites	-11177322000	-8780943000	-27.29
debt repayment	4464245000	-2905020000	253.67
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-6834238000	-6274797000	-8.92
net cash used provided by financing activities	-5366691000	-11211851000	52.13
cash at end of period	46067025000	47607566000	-3.24
accounts receivables	-38827807000	-12498170000	-210.67
cash at beginning of period	47607566000	43277994000	10.00

Overall Score of Annual Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -1,541 million in 2023 from 4,330 million in 2022 representing a change of -135.58%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 14,722 million in 2023 from 23,953 million in 2022 representing a change of -38.54%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 6,618 million in 2023 from 16,536 million in 2022 representing a change of -59.98%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables increased to 38,828 million in 2023 from 12,498 million in 2022 representing a change of 210.67%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -6,834 million in 2023 from -6,275 million in 2022 representing a change of -8.92%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -8,104 million in 2023 from -7,417 million in 2022 representing a change of -9.25%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -38,828 million in 2023 from -12,498 million in 2022 representing a change of -210.67%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	0	-12642651000	100.00
free cash flow	-1595978000	-15315240000	89.58
capital expenditure	-1595978000	-2672589000	40.28
depreciation and amortization	0	3969264000	-100.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	6012333000	-100.00
accounts payables	0	0	NaN
inventory	0	-19558554000	100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-1595978000	-2672589000	40.28
net cash used for investing activites	3330078000	-9469783000	135.17
debt repayment	987859000	-6055044000	116.31
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-6012578000	-315426000	-1806.18
net cash used provided by financing activities	-6026811000	-2118992000	-184.42
net change in cash	3066877000	-24295989000	112.62
cash at end of period	35552037000	32485160000	9.44
cash at beginning of period	32485160000	56781149000	-42.79

Overall Score of Quarterly Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 3,067 million in 2024Q3 from -24,296 million in 2024Q2 representing a change of 112.62%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 0 million in 2024Q3 from -12,643 million in 2024Q2 representing a change of 100.0%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -1,596 million in 2024Q3 from -15,315 million in 2024Q2 representing a change of 89.58%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2024Q3 from 6,012 million in 2024Q2 representing a change of -100.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -1,596 million in 2024Q3 from -2,673 million in 2024Q2 representing a change of 40.28%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Dividends Paid: Dividends Paid decreased to -6,013 million in 2024Q3 from -315 million in 2024Q2 representing a change of -1806.18%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	8.2	7.77	5.57
net income per share	0.41	0.41	0.97
operating cash flow per share	0.52	0.83	-38.25
free cash flow per share	0.23	0.58	-59.79
cash per share	2.27	2.28	-0.19
book value per share	6.88	6.65	3.38
tangible book value per share	6.26	6.06	3.31
shareholders equity per share	5.64	5.4	4.31
interest debt per share	0.59	0.99	-41.00
market cap	149965302438	146651195040	2.26
enterprise value	110695371438	119137144040	-7.09
pe ratio	12.8	12.58	1.75
price to sales ratio	0.64	0.66	-2.68
pocfratio	10.19	6.12	66.38
pfcf ratio	22.66	8.87	155.51
pb ratio	0.93	0.95	-1.51
ptb ratio	0.93	0.95	-1.51
ev to sales	0.47	0.53	-11.58
enterprise value over ebitda	4.37	4.77	-8.47
ev to operating cash flow	7.52	4.97	51.18
ev to free cash flow	16.73	7.2	132.16
earnings yield	0.08	0.08	-1.72
free cash flow yield	0.04	0.11	-60.86
debt to equity	0.1	0.18	-41.33
debt to assets	0.04	0.06	-42.91
net debt to ebitda	-1.55	-1.1	-40.60
current ratio	1.26	1.28	-1.64
interest coverage	220.89	13.92	1486.50
income quality	1.26	1.67	-24.68
dividend yield	0.05	0.04	29.37
payout ratio	0.58	0.44	31.64
sales general and administrative to revenue	0.02	0.02	-5.88
research and ddevelopement to revenue	0.06	0.06	4.11
intangibles to total assets	0.04	0.04	-2.84
capex to operating cash flow	0.55	0.31	77.76
capex to revenue	0.03	0.03	3.97
capex to depreciation	1.03	0.95	8.56
stock based compensation to revenue	0	0	NaN
graham number	7.21	7.03	2.63
roic	0.06	0.06	4.15
return on tangible assets	0.03	0.03	-5.92
graham net net	-1.93	-1.4	-37.95
working capital	64179957000	63051299000	1.79
tangible asset value	178779305000	173871737000	2.82
net current asset value	39319043000	39300820000	0.05
invested capital	148647813000	146547970000	1.43
average receivables	157475692000	149312722500	5.47
average payables	133700964000	109277963500	22.35
average inventory	64992377500	62278018000	4.36
days sales outstanding	253.4	249.37	1.62
days payables outstanding	310.65	233.64	32.96
days of inventory on hand	133.99	131.21	2.12
receivables turnover	1.44	1.46	-1.59
payables turnover	1.17	1.56	-24.79
inventory turnover	2.72	2.78	-2.07
roe	0.07	0.08	-3.20
capex per share	0.28	0.26	9.77

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 12.80 on 2023-12-31 from 12.58 on 2022-12-31, representing a change of 1.75%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.10 on 2023-12-31 from 0.18 on 2022-12-31, representing a change of -41.33%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.26 on 2023-12-31 from 1.28 on 2022-12-31, representing a change of -1.64%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
1766.HK
calendar year	2024	2024	NaN
revenue per share	2.18	2.0	8.92
net income per share	0.11	0.11	-4.65
operating cash flow per share	0.21	-0.43	148.27
free cash flow per share	0.15	-0.52	127.79
cash per share	1.93	1.97	-1.97
book value per share	7.1	7.16	-0.78
tangible book value per share	6.49	6.55	-0.84
shareholders equity per share	5.7	5.59	1.93
interest debt per share	0.57	1.89	-69.73
market cap	234469718880	218685343680	7.22
enterprise value	202017809880	224756019680	-10.12
pe ratio	19.26	17.12	12.45
price to sales ratio	3.75	3.81	-1.56
pocfratio	39.25	-17.67	322.12
pfcf ratio	56.08	-14.53	485.88
pb ratio	1.43	1.36	5.19
ptb ratio	1.43	1.36	5.19
ev to sales	3.23	3.91	-17.48
enterprise value over ebitda	55.09	32.03	72.01
ev to operating cash flow	33.82	-18.16	286.20
ev to free cash flow	48.32	-14.94	423.49
earnings yield	0.01	0.01	-11.07
free cash flow yield	0.02	-0.07	125.91
debt to equity	0.1	0.34	-70.27
debt to assets	0.03	0.11	-70.90
net debt to ebitda	-8.85	0.87	-1123.04
current ratio	1.24	1.25	-0.83
interest coverage	29.73	6.44	361.44
income quality	1.96	-3.88	150.62
dividend yield	0.02	0.03	-6.73
payout ratio	1.89	1.8	4.88
sales general and administrative to revenue	0.13	-0.02	690.66
research and ddevelopement to revenue	0.06	0.05	14.91
intangibles to total assets	0.03	0.04	-4.09
capex to operating cash flow	0.27	-0.22	223.71
capex to revenue	0.03	0.05	-45.17
capex to depreciation	0	1.35	-100.00
stock based compensation to revenue	0	0	NaN
graham number	3.69	3.74	-1.41
roic	0.02	0.01	31.41
return on tangible assets	0.01	0.01	-8.60
graham net net	-2.35	-1.9	-23.92
working capital	65653634000	64017975000	2.55
tangible asset value	186344940000	187931081000	-0.84
net current asset value	41431940000	43547920000	-4.86
invested capital	151836468000	148980094000	1.92
average receivables	166805992000	149364153999.5	11.68
average payables	175719555000	182333169500	-3.63
average inventory	89525812000	83934563500	6.66
days sales outstanding	246.17	254.76	-3.37
days payables outstanding	303.38	352.39	-13.91
days of inventory on hand	168.99	164.42	2.78
receivables turnover	0.37	0.35	3.49
payables turnover	0.3	0.26	16.16
inventory turnover	0.53	0.55	-2.70
roe	0.02	0.02	-6.45
capex per share	0.06	0.09	-40.28

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q3 from 0.02 on 2024-06-30 Q2, representing a change of -6.45%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 19.26 on 2024-09-30 Q3 from 17.12 on 2024-06-30 Q2, representing a change of 12.45%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.10 on 2024-09-30 Q3 from 0.34 on 2024-06-30 Q2, representing a change of -70.27%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.24 on 2024-09-30 Q3 from 1.25 on 2024-06-30 Q2, representing a change of -0.83%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 9.42 which is higher than current price 4.95, indicates the company may be undervalued.